Revelation Biosciences, Inc. (REVBW) stock
REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $16.05MP/E –Yield –
Revelation Biosciences statistics
55 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Nov 5, 2026 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Oct 30, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.59
- 2.47
Share statisticsIndustry
- Shares Change (QoQ)
- 0.00%
- 0.54%
- Float
- 3M
- 49M
- Shares Held by Insiders
- 26.8%
- 11.4%
- Shares Held by Institutions
- 35.3%
- 56.1%
Short sellingIndustry
- Short Interest
- 1,581
- –
- Short Interest Change
- 517.6%
- 0.60%
- Days to Cover
- 1.00
- 4.58
Stock price statisticsIndustry
- 52-Week High
- $40.60
- –
- 52-Week Low
- $3.08
- –
- 20-Day Moving Average
- $4.42
- –
- 50-Day Moving Average
- $5.77
- –
- 200-Day Moving Average
- $8.16
- –
- Average True Range (14)
- $0.43
- –
- Price Change (1 Week)
- 6.33%
- 1.30%
- Price Change (1 Month)
- -28.1%
- -7.60%
- Price Change (3 Months)
- -43.6%
- -14.4%
- Price Change (6 Months)
- -48.6%
- -19.7%
- Price Change (YTD)
- -82.0%
- -19.6%
- Price Change (1 Year)
- -88.8%
- -21.9%
- Price Change (3 Years)
- -100.0%
- -22.6%
- Price Change (5 Years)
- -100.0%
- -75.5%
- Average Volume (10 Days)
- 33,508
- –
- Average Volume (20 Days)
- 23,808
- –
- Average Volume (90 Days)
- 9,626
- –
- Relative Volume
- 2.36
- 0.73
- Relative Strength Index (14)
- 39.7
- 44.2
- Volatility (1 Year)
- 81.1%
- 79.5%
- Beta (5 Years)
- 1.24
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -154.8%
- -53.1%
- Return on Assets (ROA)
- -120.2%
- -40.9%
- Return on Capital Employed (ROCE)
- -106.1%
- -38.6%
Financial positionIndustry
- Current Ratio
- 6.21
- 3.30
- Quick Ratio
- 6.11
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$1.34M
- -$705.27K
- Employee Count
- 8
- 75
- WACC
- 11.2%
- 10.1%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $11.48M
- $15.31M
- Net Cash Per Share
- $2.88
- $0.66
- Equity (Book Value)
- $10.07M
- $48.79M
- Book Value Per Share
- $2.53
- $1.36
- Tangible Book Value
- $10.07M
- $23.91M
- Working Capital
- $9.80M
- $74.41M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -67.0%
- -20.7%
Scores and fair valueIndustry
- Altman Z-Score
- -4.32
- 0.25
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.
| Period | REVBW | S&P 500 | Difference | REVBW per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -27.4% | -0.9% | −26.5 pts | ||
| 3 months | -45.9% | +2.1% | −48.1 pts | ||
| Year to date | -33.8% | +11.7% | −45.4 pts | ||
| 1 year | -55.8% | +12.4% | −68.2 pts | ||
| 3 years | -55.8% | +88.6% | −144.4 pts | -23.8% | +23.5% |
| 5 years | -99.1% | +75.9% | −175.1 pts | -61.2% | +12.0% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.
0M REVBW shares were sold short on Oct 15, 2026, down 63.0% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 52.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 15, 2026 | 2,237 | -63.0% | 30,036 | 1.0 |
| Sep 30, 2026 | 6,042 | +1.2% | 23,548 | 1.0 |
| Sep 15, 2026 | 5,973 | 0.0% | 3,138 | 1.9 |
| Aug 31, 2026 | 5,973 | +3.8% | 3,109 | 1.9 |
| Aug 14, 2026 | 5,756 | +45.5% | 562 | 10.2 |
| Jul 31, 2026 | 3,956 | +12.2% | 3,572 | 1.1 |
| Jul 15, 2026 | 3,525 | +6.1% | 11,264 | 1.0 |
| Jun 30, 2026 | 3,321 | -0.2% | 12,745 | 1.0 |
| Jun 15, 2026 | 3,327 | +0.6% | 28,617 | 1.0 |
| May 29, 2026 | 3,307 | +184.6% | 80,422 | 1.0 |
| May 15, 2026 | 1,162 | -97.6% | 202,279 | 1.0 |
| Apr 30, 2026 | 48,365 | -35.0% | 22,278 | 2.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.